Growth hormone and seawater adaptation in coho salmon, Oncorhynchus kisutch.
1. Effects of growth hormone (GH) were examined on short-term aspects of seawater adaptation in coho salmon smolts. 2. Injection of somatostatin (SRIF) immediately prior to seawater entry suppressed plasma GH levels, but did not have any significant effects at 6 or 12 hr on hematocrits, plasma glucose or plasma Na+ levels. 3. Plasma GH levels increased 250% within 36 hr after seawater exposure. 4. Plasma glucose levels, in contrast, were significantly lower in the seawater fish after 36 hr post-exposure. 5. Plasma Na+ levels increased to 190 mEq/1 by 24 hr but subsequently returned to freshwater levels while hematocrits showed no significant changes over the 72 hr of exposure. 6. The significance of these results is discussed in terms of successful seawater adaptation in coho salmon.
D000064:Acclimatization / Q000187:drug effects; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D005618:Fresh Water; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism*; D012474:Salmon / Q000502:physiology*; D012623:Seawater; D012964:Sodium / Q000097:blood; D013004:Somatostatin / Q000494:pharmacology*
D001786:Blood Glucose; D013004:Somatostatin; D013006:Growth Hormone; D012964:Sodium